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CASE REPORT
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INTRODUCTION
Cryptococcosis is the most common 
fungal infection to strike the Central Nervous 
System. Its sub-acute manifestation includes 
fever, headache, nausea, and changes in 
behavior. Dysacousia takes place in up to 
27% of patients, almost always bilaterally 
and suddenly1. Reversibility is rare and was 
described by Mayer et al. in 1990. In general 
terms, if no treatment is offered death is the 
ultimate consequence.
CASE STUDY
AJGG, female, 29 years of age, arrived 
in our center on December 25, 2003 with in-
tense headache, discomfort, nausea, diplopia 
and reduced visual acuity; the symptoms had 
begun manifesting themselves two months 
before.
Her neck was stiff and the right ab-
ducens paretic. CBC came back normal and 
the quick HIV test was negative. Latex test, 
nankin dye and LCR indicated Cryptococcosis. 
CT scan revealed cerebral edema.
The patient evolved to hypoacousia 
and then quickly to blindness and bilateral 
total hearing loss. The otolaryngological 
evaluation was normal, except for the paretic 
abducens.
The patient’s condition made it im-
possible for audiometric tests to be conduc-
ted. BERA had thresholds at 110 dBSPL to the 
right and 100 dBSPL to the left, compatible 
with severe bilateral hearing loss for clicks. It 
was not possible to collect duplicated respon-
ses at 130 dBNPL and thus waves I, III and 
V were not analyzed. Otoacoustic emissions 
were normal.
Treatment was initiated with intrave-
nous Amphotericin B 50mg/day, getting to 
a dose of 1725 mg. The patient required a 
number of relief spinal taps and a ventriculo-
peritoneal shunt.
After 100 days in the hospital the 
patient improved clinically and was dischar-
ged without headache and neck stiffness, 
with partially recovered auditory acuity 
(picture) and multiple negative LCR cultures 
for fungi.
DISCUSSION
Cryptococcal meningitis may occur 
at any given age and is more prevalent in 
immunologically compromised patients 1.
Hypoacousia is described in as many 
as 27% of patients and may fluctuate1, with 
losses ranging from moderate unilateral to 
severe bilateral2. The mechanism leading to 
lesions in the auditory system has been stu-
died. Igarashi et al.3 and Kwartler et al.4 have 
seen destruction of cochlear and vestibular 
structures, with the presence of microorga-
nisms in the vestibulocochlear nerve, internal 
auditory meatus and cochlear structures. 
Harada et al.5 have seen most of these alte-
rations, however with normal Corti’s organ 
and preserved vestibular nerve in relation 
to the cochlear nerve. Therefore, despite the 
apparent disagreement as to the involvement 
of the cochlea, all authors concur that there is 
retrocochlear damage2. In this sense, normal 
otoacoustic emissions suggest preservation of 
the Corti’s organ.
Mayer et al. described Hypoacousia 
reversibility in 19908. The mechanism is ho-
wever not fully comprehended.
Treatment of HIV-negative patients is 
done with amphotericin B and/or flucytosine 
for 6-10 weeks. This is a severe, potentially 
deadly disease.
CONCLUSIONS
Cryptococcal meningitis is a severe 
infection and its clinical signs are of diffi-
cult diagnosis. Auditory involvement seems 
frequent, and its reversibility, rare. Early 
treatment is therefore of utmost importance, 
as is audiometric monitoring in the cases 
being followed.
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